Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Melanoma × Circulating Tumor DNA × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Vulvar Neoplasms 1 Prostatic Neoplasms 1 Melanoma 1 Hypoxia 1 Colorectal Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Blood Specimen Collection 14 Nivolumab 11 Ipilimumab 11 pembrolizumab 10 Surveys and Questionnaires 8 Gene Expression Profiling 8 trametinib 7 dabrafenib 6 Immunohistochemistry 5 Biopsy 5 Specimen Handling 4 Immunotherapy 4 Amplified Fragment Length Polymorphism Analysis 4 atezolizumab 3 Restraint, Physical 3 Polymerase Chain Reaction 3 Introns 3 Flow Cytometry 3 Data Collection 3 tremelimumab 2 aldesleukin 2 Watchful Waiting 2 Therapeutics 2 Surgical Procedures, Operative 2 Methods 2 Magnetic Resonance Spectroscopy 2 Liquid Biopsy 2 Interferon-alpha 2 Histocompatibility Testing 2 Drug Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05940311 2024-11-27

VerSiLiB

Regina Elena Cancer Institute

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡